Danaher Corporation (DHR)
| Previous close | 248.76 |
| Open | 249.30 |
| Bid | 249.35 x 900 |
| Ask | 249.46 x 800 |
| Day's range | 248.15 - 249.82 |
| 52-week range | 182.09 - 259.00 |
| Volume | |
| Avg. volume | 2,584,708 |
| Market cap | 184.729B |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | 45.76 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.08 (0.43%) |
| Ex-dividend date | 27 Mar 2024 |
| 1y target est | N/A |
- PR Newswire
Danaher to Present at Bank of America Securities Healthcare Conference
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Tuesday, May 14, 2024 at 10:40 a.m. PT. The event will be simultaneously webcast on www.danaher.com.
- PR Newswire
Danaher Announces Quarterly Dividend
Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on July 26, 2024 to holders of record on June 28, 2024.
- PR Newswire
Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry
Curiox Biosystems Co. Ltd (Curiox), a leader in the innovation of life science research technologies, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announce a strategic partnership to provide researchers with a one-stop solution for hands-free washed sample preparation for flow cytometry.
